Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF) Sees Significant Decrease in Short Interest

Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totaling 25 shares, a decrease of 99.9% from the April 30th total of 30,720 shares. Based on an average daily trading volume, of 6,568 shares, the short-interest ratio is presently 0.0 days.

Voyageur Pharmaceuticals Stock Performance

OTCMKTS VYYRF remained flat at $0.06 during mid-day trading on Wednesday. The business has a 50 day simple moving average of $0.09 and a two-hundred day simple moving average of $0.10. Voyageur Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.24.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals, Inc is a biopharmaceutical company specializing in advanced drug-delivery technologies and contract development services. The company focuses on formulating and optimizing therapeutic compounds to enhance stability, bioavailability and controlled-release properties. By leveraging proprietary polymer- and lipid-based delivery platforms, Voyageur aims to partner with pharmaceutical and biotechnology firms to address formulation challenges in high-value therapeutic areas, including oncology, endocrinology and central nervous system disorders.

The company’s core offerings include formulation development, analytical testing, preclinical evaluation and small-scale manufacturing support.